SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001819934-22-000003
Filing Date
2022-06-01
Accepted
2022-05-31 19:48:24
Documents
1
Effectiveness Date
2022-06-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 14095
  Complete submission text file 0001819934-22-000003.txt   15229
Mailing Address 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address 953 INDIANA STREET SAN FRANCISCO CA 94107 (415) 235-6373
Ambagon Therapeutics Inc. (Filer) CIK: 0001819934 (see all company filings)

IRS No.: 850560627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-429995 | Film No.: 22985391